JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A5065 Bicalutamide
1 Citation

Target: Androgen Receptors

Summary: Androgen receptor antagonist

≥42.89 mg/mL
A8623 TOK-001

Target: Androgen Receptors|Cytochrome P450 (CYP450)

Summary: CYP17 inhibitor and androgen receptor (AR) antagonist

insoluble in H2O; ≥12.4 mg/mL
B3238 XCT790

Target: Estrogen and Related Receptors

Summary: ERRα agonist

insoluble in H2O; ≥14.9 mg/mL
B1515 Raloxifene HCl

Target: Estrogen and Related Receptors

Summary: Estrogen receptor (ER)

≥22.35 mg/mL
B5421 (Z)-4-Hydroxytamoxifen

Target: Estrogen and Related Receptors

Summary: ER modulator, potent and selective

≥38.8 mg/mL
B5455 G-1
4 Citation

Target: GPR30

Summary: GPR30 agonist, potent and selective

≥41.2 mg/mL
B5469 G-15
3 Citation

Target: GPR30

Summary: GPER receptor antagonist

insoluble in H2O; insoluble in EtOH; ≥37 mg/mL
B1518 Erteberel (LY500307)

Target: Estrogen and Related Receptors

Summary: ERβ agonist, potent and selective

insoluble in H2O; ≥14.1 mg/mL
B1510 Medroxyprogesterone acetate

Target: Progesterone Receptors

Summary: Steroidal progestin
B6429 Naltrindole hydrochloride

Summary: δ opioid antagonist

Soluble in DMSO